Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies (Tables)

v3.25.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The following is a description of the valuation methodologies used for assets measured at fair value as of September 30, 2025 and December 31, 2024.

 

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

   

Quoted Prices in
Active Markets
for Identical
Assets or
Liabilities

(Level 1)

   

Quoted Prices

for Similar Assets

or Liabilities

in Active

Markets
(Level 2)

    Significant
Unobservable
Inputs (Level 3)
 
Marketable securities at September 30, 2025   $ 3,091,772     $        -     $          -  
                         
Marketable securities at December 31, 2024   $ 8,345,081     $ -     $ -  
Contingent consideration payable at September 30, 2025                   $ 9,380,000  
Contingent consideration payable at December 31, 2024                   $ 0  
Schedule of Fair Value Hierarchy of the Valuation Inputs

 

          As of  
Description   Level    

September 30,

2025

   

December 31,

2024

 
Liabilities                        
Warrant Liabilities     3     $          -     $ -  
Derivative Liabilities     3     $ 2,896,000     $ 1,303,000  
Summary of Change in Fair Value of Warrant Liabilities

The following table sets forth a summary of the change in the fair value of the warrant liabilities that is measured at fair value on a recurring basis for the nine months ended September 30, 2025 and September 30, 2024, respectively:

 

Description   2025     2024  
Balance on December 31, 2024 and 2023   $    -     $ 867,000  
Issuance of warrants reported at fair value     -       -  
Change in fair value of warrant liabilities     -       7,094,000  
Reclassification of warrant liability to equity upon warrant modification     -       (7,961,000 )
Balance on March 31,     -       -  
Issuance of warrants reported at fair value     -       21,992,000  
Change in fair value of warrant liabilities     -       (2,701,000 )
Balance on June 30,     -       19,291,000  
Issuance of warrants reported at fair value     -       -  
Change in fair value of warrant liabilities     -       17,000  
Reclassification of warrant liability to equity upon warrant modification     -       (19,308,000 )
Balance on September 30,   $ -     $ -
Summary of Change in Fair Value of Derivative Liabilities

The following table sets forth a summary of the change in the fair value of the derivative liabilities that is measured at fair value on a recurring basis for the nine months ended September 30, 2025 and September 30, 2024, respectively:

 

Description   2025     2024  
Balance on December 31, 2024 and 2023   $ 1,303,000     $ 61,000  
Issuance of derivatives reported at fair value     -       -  
Changes in fair value of derivative liabilities     (1,284,000 )     (61,000 )
Balance on March 31,     19,000       -  
Issuance of derivatives reported at fair value     -       854,000  
Change in fair value of derivative liabilities     (19,000 )     72,000  
Balance on June 30,     -       926,000  
Issuance of derivatives reported at fair value     1,837,000       -  
Change in fair value of derivative liabilities     1,059,000       356,000  
Balance on September 30,   $ 2,896,000       1,282,000  
Schedule of Estimated Useful Lives of Property Plant and Equipment

The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the remaining lease or estimated useful life
Schedule of Estimated Useful Lives of Intangible Assets

Amortization is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that they are available for use. The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Patents and trademarks   12-17
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease

The Company’s operating leases are comprised of the 2021 Baltimore Lease and the 2024 Baltimore Lease on the Condensed Consolidated Balance Sheets. The information related to these leases is presented below:

 

    2024 Baltimore           2021 Baltimore     2024 Baltimore        
    As of September 30, 2025     As of December 31, 2024  
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Balance Sheet Location   Lease     Total     Lease     Lease     Total  
Operating Lease                                        
Lease Right of Use   $        -     $    -     $        -     $ 10,579     $ 10,579  
Lease Payable, current     -       -       -       10,579       10,579  
Schedule of Lease Expense

The following provides details of the Company’s lease expense:

 

    2024 Baltimore           2021 Baltimore     2024 Baltimore        
   

For the Three Months Ended

September 30, 2025

   

For the Three Months Ended

September 30, 2024

 
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Lease Expenses   Lease     Total     Lease     Lease     Total  
Operating Leases                                                              
Lease Costs   $ -     $ -       -     $ 8,100     $ 8,100  

 

    2024 Baltimore           2021 Baltimore     2024 Baltimore        
   

For the Nine Months Ended

September 30, 2025

   

For the Nine Months Ended

September 30, 2024

 
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Lease Expenses   Lease     Total     Lease     Lease     Total  
Operating Leases                                        
Lease Costs   $ 10,800     $ 10,800     $ 18,672     $ 13,500     $ 32,172  
Schedule of Other Information Related to Leases

Other information as of September 30, 2025 related to leases is presented below:

 

    2024 Baltimore        
Other Information   Lease     Total  
Operating Leases                
Operating cash used   $ 10,800     $ 10,800  
Average remaining lease term     -       -  
Average discount rate     10.0 %     10.0 %
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

For the three and nine months ended September 30, 2025 and 2024, the following securities are excluded from the calculation of weighted average dilutive Common Stock because their inclusion would have been anti-dilutive.

 

    2025     2024     2025     2024  
    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2025     2024     2025     2024  
Stock Options     2,819       1,037       1,943       1,281  
Unvested Restricted Stock Units     484       488       484       754  
Warrants to purchase Common Stock     4,823,701       239,809       2,539,277       139,353  
Series C Convertible Preferred Stock Warrants     -       10       -       10  
Series D Convertible Preferred Stock     13       13       13       13  
Series F Convertible Preferred Stock     -       2,574,339       -       2,574,339  
Series F-1 Convertible Preferred Stock     -       2,780,837       -       2,780,837  
Series G Convertible Preferred Stock     2,657,135       4,928,414       2,598,701       4,187,775  
Series H Convertible Preferred Stock     1,799,603       -       1,799,603       -  
Series I Convertible Preferred Stock     665,030       -       665,030       -  
Total potentially dilutive shares     7,484,152       10,524,147       5,140,418       9,684,362